Evidence map›Paper›PMID 36962910›Full record

ArticlePLOS global public health2022

Community-based referral for tuberculosis preventive therapy is effective for treatment completion.

Sheela V Shenoi, Tassos C Kyriakides, Emily Kainne Dokubo, Vijayanand Guddera, Peter Vranken, Mitesh Desai, Gerald Friedland, Anthony P Moll

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Sheela V ShenoiSection of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.ORCID https://orcid.org/0000-0001-7654-4344
Tassos C KyriakidesYale School of Public Health, Biostatistics, Yale Center for Analytical Sciences, New Haven, Connecticut, United States of America.
Emily Kainne DokuboU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Vijayanand GudderaPhilanjalo NGO, Tugela Ferry, South Africa.
Peter VrankenU.S. Centers for Disease Control and Prevention, Pretoria, South Africa.
Mitesh DesaiDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Gerald FriedlandSection of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
Anthony P MollPhilanjalo NGO, Tugela Ferry, South Africa.
Centers for Disease Control and Prevention · USYale University · USPhilanjalo · ZASouth African Medical Research Council · ZAUniversity of Pretoria · ZA

Funding

Community-Based Intensive Case Finding for HIV, TB, and MDR/XDR TB in Rural SouthK23AI089260 · NIAID · YALE UNIVERSITY · PI SHENOI, SHEELA · 2011 to 2015
$668k
CGH CDC HHS U01 GH000524CGH CDC HHS U2G GH001652NIAID NIH HHS K23 AI089260
6 · The paper itself

Abstract

Expansion of tuberculous preventive therapy (TPT) is essential to curb TB incidence and mortality among people with HIV (PWH), yet implementation has been slow. Innovative strategies to operationalize TPT are urgently needed. Here we present an evaluation of community-based identification and referral of PWH on completion of a six-month course of isoniazid in a highly prevalent region in rural South Africa. Using a community-based TB/HIV intensive case finding strategy, a team of nurses and lay workers identified community members with HIV who were without fever, night sweats, weight loss, or cough and referred them to the government primary care clinics for daily oral isoniazid, the only available TPT regimen. We measured monthly adherence and six-month treatment completion in the community-based identification and referral (CBR) group compared to those already engaged in HIV care. Adherence was measured by self-report and urine isoniazid metabolite testing. A multivariable analysis was performed to identify independent predictors of TPT completion. Among 240 participants, 81.7% were female, median age 35 years (IQR 30-44), and 24.6% had previously been treated for TB. The median CD4 count in the CBR group was 457 (IQR 301-648), significantly higher than the clinic-based comparison group median CD4 of 344 (IQR 186-495, p<0.001). Independent predictors of treatment completion included being a woman (aOR 2.41, 95% 1.02-5.72) and community-based identification and referral for TPT (aOR 2.495, 95% 1.13-5.53). Among the CBR group, treatment completion was 90.0%, an absolute 10.8% higher than the clinic-based comparison group (79.2%, p = 0.02). Adherence was significantly greater in the CBR group than the clinic-based comparison group, as measured by self-report (p = 0.02) and urine isoniazid testing (p = 0.01). Among those not on ART at baseline, 10% of eligible PWH subsequently initiated ART. Community members living with HIV in TB endemic regions identified and referred for TPT demonstrated higher treatment completion and adherence compared to PWH engaged for TPT while receiving clinic-based care. Community-based identification and referral is an innovative adjunctive strategy to facilitate implementation of TB preventive therapy in people living with HIV.

Identifiers

PMID36962910
PMCPMC10021376
OpenAlexW4311439658

What OpenQuestion holds

Textfull text, public
LicenceCC0
measurements read68
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.